We've put humans on the moon, eradicated smallpox, and sequenced the entire human genome. So why, after more than a century of research and hundreds of billions of dollars in funding, haven't we cured cancer?
The question comes up every time a new breakthrough makes headlines — and every time another person loses their fight. It feels like cancer should have been solved by now. But the reason it hasn't been isn't a failure of science, funding, or effort. It's that the question itself contains a fundamental misunderstanding of what cancer actually is.
Cancer is not one disease. It's a category of over 200 distinct diseases, each driven by different genetic mutations, each behaving differently in different people. Asking "why can't we cure cancer?" is like asking "why can't we cure infection?" — it ignores the enormous diversity hiding behind a single word.
That said, the picture isn't nearly as bleak as the question implies. Cancer death rates have been falling steadily for decades. Survival rates for many cancers have doubled or tripled since the 1970s. And the treatments available today would have seemed like science fiction just 30 years ago.
This article explains why cancer is so uniquely difficult to defeat, how treatment has evolved from crude surgery to precision molecular therapy, what actually works in prevention, and what you can do — starting today — to meaningfully reduce your risk.
Cancer Is Not a Foreign Invader — It's You
The first thing that makes cancer fundamentally different from virtually every other disease is this: cancer cells are your own cells. They're not bacteria you can target with antibiotics. They're not viruses you can train your immune system to recognize. They are cells that were once perfectly normal, part of your body's everyday machinery, until something went wrong in their DNA.
Cancer develops when mutations accumulate in genes that control cell growth, division, and death. Normally, your body has multiple failsafes — tumor suppressor genes that act as brakes, DNA repair mechanisms that catch errors, and programmed cell death (apoptosis) that eliminates damaged cells before they can cause harm. Cancer happens when enough of these safeguards fail in a single cell line.
The causes are varied: inherited genetic predisposition, exposure to carcinogens (tobacco smoke, UV radiation, certain chemicals), chronic infections like hepatitis C or HPV, or sometimes pure randomness — a copying error during routine cell division that no one could have prevented.
Once a cell becomes cancerous, it has several properties that make it extraordinarily hard to stop:
Uncontrolled division. Cancer cells don't need the normal signals from surrounding tissue to keep dividing. Unlike healthy cells, which have a built-in limit on how many times they can replicate (the Hayflick limit), cancer cells are effectively immortal — they can divide indefinitely.
Metastasis. Cancer cells don't stay put. They break away from the original tumor and travel through the bloodstream and lymphatic system to colonize distant organs. The speed and pattern of spread depend not on tumor size but on how abnormal the cells are — the more mutated, the more aggressive.
Evolution in real time. Cancer cells constantly mutate. When treatment kills most of the tumor, the survivors are by definition the most resistant cells. They repopulate the tumor, now carrying resistance to whatever killed their predecessors. Even dying cancer cells send chemical signals that accelerate the growth of surviving cells.
Hijacking the host. Cancer cells don't just grow passively — they actively reshape their environment. They recruit blood vessels to feed themselves (angiogenesis), suppress the local immune response, and even conscript normal neighboring cells to support their growth. Brain tumors, for example, have been shown to rewire neural synapses to stimulate their own proliferation.
Staggering diversity. There are more than 200 types of cancer, and even cancers of the same organ — breast cancer, for instance — can involve dozens of different genetic mutation patterns. Two patients with "the same cancer" may have diseases that behave completely differently and respond to entirely different treatments.
This is why there will likely never be a single "cure for cancer." It's the wrong frame. The real question is how to cure — or effectively manage — each of the hundreds of distinct diseases we currently group under one name.
What "Curing" Cancer Actually Means
When oncologists talk about cancer outcomes, they're careful with their language — and for good reason.
Complete remission means all detectable signs of cancer have disappeared. But "detectable" is the operative word. Current diagnostic technology can't find tiny numbers of remaining cancer cells. If even 0.01% of cancer cells survive, they can eventually regrow into a new tumor — weeks, months, or even years later.
This is why doctors use the term "remission" rather than "cure." A patient in remission has no measurable disease, but the possibility of recurrence remains. Generally, if complete remission lasts five or more years, the cancer is considered cured — because the probability of return decreases with each passing year.
This distinction matters because it shapes treatment strategy. Oncologists don't just treat until the tumor is gone — they continue treatment afterward, sometimes for months or years, trying to eliminate every last cancer cell. The treatments themselves — chemotherapy, radiation, immunotherapy — come with serious side effects, so there's always a balance between aggressive enough to kill the cancer and tolerable enough for the patient to survive the treatment.
For some cancers, this balance works well. For others, particularly aggressive or late-stage cancers, the best achievable outcome may be converting the disease into something chronic and manageable — keeping it in check for years, the way we manage diabetes or rheumatoid arthritis, rather than eradicating it completely.
A Century of Progress: From Radical Surgery to Precision Medicine
The history of cancer treatment is a story of ambition, overreach, correction, and genuine progress — often all at once.
Surgery: The Era of "More Is Better"
Before anesthesia and antiseptics, cancer was essentially untreatable. Beginning in the 19th century, surgeons learned to remove tumors of the breast, prostate, uterus, and colon with increasing success. But tumors kept coming back, even after apparently complete removal.
This led to a seductive but damaging idea: if some surgery is good, more surgery must be better. In 1894, American surgeon William Halsted developed the radical mastectomy, removing not just the breast but all underlying chest muscles and nearby lymph nodes. His followers went even further, performing increasingly mutilating procedures. The philosophy dominated oncology through the mid-20th century.
By the 1950s, evidence was already accumulating that radical surgery was no more effective than less extensive procedures — patients survived the same duration regardless of how much tissue was removed. But it took until the late 1970s for Halsted's approach to be abandoned as the standard, replaced by lumpectomy combined with radiation and chemotherapy.
Chemotherapy: Poison as Medicine
The idea of using chemicals to kill cancer cells emerged, remarkably, from chemical warfare. Researchers at Yale discovered that derivatives of mustard gas — the devastating World War I weapon — could shrink lymphomas. In 1947, oncologist Sidney Farber began testing anti-folate compounds on children dying of leukemia, achieving the first temporary remissions.
From the 1950s onward, scientists tested hundreds of chemical compounds against cancer cells. They discovered that combining multiple drugs killed more cancer cells than any single agent alone. Chemotherapy became effective against leukemias, lymphomas, and several solid tumors.
But chemotherapy has a fundamental limitation: it kills all rapidly dividing cells, not just cancerous ones. That's why it destroys bone marrow, causes hair loss, and damages the gut lining. Push the dose too high and the treatment itself becomes lethal. The development of bone marrow transplantation in 1956 allowed higher chemotherapy doses by replacing the destroyed marrow afterward — a technique still used today for blood cancers.
Radiation: Learning to Aim
Radiation therapy was first used against cancer at the start of the 20th century, but early machines couldn't target tumors precisely, causing severe collateral damage to healthy tissue. Modern innovations like 3D-conformal radiation therapy and stereotactic radiosurgery can now deliver focused beams that match the exact shape and volume of a tumor, dramatically reducing side effects.
Targeted Therapy: Attacking the Broken Genes
Once scientists understood that cancer is fundamentally a disease of damaged genes, they could design drugs that target the specific molecular defects driving each tumor, while largely sparing normal cells. These "targeted therapies" now include dozens of approved drugs.
The results have been transformative for some cancers. Chronic myeloid leukemia, once rapidly fatal, can now be controlled for years — and some patients can even stop treatment entirely after sustained remission. For melanoma with a BRAF gene mutation, targeted drugs can significantly slow tumor growth.
But targeted therapy has its own limitations. Tumors can develop resistance by acquiring new mutations. And not all cancers have identifiable molecular targets — for some types, the genetic differences between cancerous and normal cells are too subtle to exploit.
Immunotherapy: Teaching the Body to Fight Back
Immunotherapy may be the most exciting development in cancer treatment in decades. Rather than attacking cancer directly, these drugs help the patient's own immune system recognize and destroy cancer cells — or perform immune functions themselves.
The approach works remarkably well for some patients and some cancers. But response rates vary widely: only 20–50% of patients see improvement, even among those with the same type of cancer. Why immunotherapy works for some and not others remains one of oncology's most important open questions.
No single approach — surgery, chemotherapy, radiation, targeted therapy, or immunotherapy — is sufficient alone. Modern cancer treatment typically combines multiple methods, tailored to the specific type, stage, and genetic profile of each patient's disease.
The Numbers: Where Cancer Treatment Stands Today
Despite the complexity of the disease, the trajectory is undeniably positive.
Global cancer mortality has declined by about 15% since 1990, after adjusting for population aging (since older populations naturally have higher cancer rates). Five-year survival for many common cancers has improved dramatically:
- Breast cancer: 10-year survival reaches 78%
- Prostate cancer: 10-year survival reaches 84%
- Melanoma: 10-year survival reaches 87%
- Acute lymphoblastic leukemia (children): nearly 90% five-year survival, up from approximately 30% several decades ago
- Some breast cancers: 30+ year survival is now achievable
- Overall: About 18% of all cancer patients live more than 20 years after diagnosis
These gains come from three main drivers:
- Better treatment. Combination therapies, targeted drugs, and immunotherapies have improved outcomes for dozens of cancer types.
- Earlier detection. Screening programs catch cancers at earlier, more treatable stages. When cancer is found early, before it has spread, the chances of successful treatment are vastly higher.
- Prevention. Reducing exposure to known risk factors — particularly tobacco — has caused some cancers to become significantly less common.
But the news isn't uniformly good. Some cancers remain stubbornly lethal: lung cancer has a 10-year survival rate of only 4–7%, and pancreatic cancer sits below 1%. These are areas where breakthroughs are still desperately needed.
Why Early Detection Changes Everything
The single most important factor in cancer survival — more important than which drugs are used or which surgeon performs the operation — is stage at diagnosis. Catching cancer before it has spread to distant organs transforms outcomes.
Consider stomach cancer. At its earliest stage, the five-year survival rate is approximately 65%. At stage III, it drops dramatically. By stage IV, with distant metastases, the odds shrink to single digits. The cancer is biologically the same disease — what changes is the window of opportunity for treatment.
This pattern repeats across virtually every cancer type. Early-stage breast cancer has survival rates above 95%. Late-stage breast cancer remains difficult to cure. The difference is not in the treatment available — it's in when treatment begins.
This is why screening programs exist: mammograms for breast cancer, colonoscopies for colorectal cancer, PSA tests for prostate cancer, Pap smears for cervical cancer, low-dose CT scans for high-risk lung cancer patients. These tests find cancers (or pre-cancerous changes) before symptoms appear, when treatment is most effective.
The challenge is that screening isn't one-size-fits-all. Your age, sex, family history, lifestyle, and personal risk factors all determine which screenings you need and when. Missing the right screening at the right time can mean the difference between catching a treatable cancer and discovering a stage IV diagnosis.
This is one area where technology can genuinely help. WatchMyHealth's preventive health screening feature uses your health profile — age, sex, medical history, and risk factors — to generate personalized screening recommendations based on guidelines from the USPSTF, WHO, CDC, and other major health organizations. Instead of trying to navigate complex screening schedules yourself, you get a prioritized list of what to check and when, with the reasoning behind each recommendation.
What You Can Actually Control: Evidence-Based Prevention
You can't eliminate your cancer risk entirely — some risk factors, like age and inherited genetics, are beyond your control. But research consistently shows that a substantial portion of cancers are attributable to modifiable factors. The data on prevention is strong, and the strategies are straightforward.
Don't Smoke (or Quit Now)
Tobacco is the single largest preventable cause of cancer worldwide. It's linked not only to lung cancer but to cancers of the mouth, throat, esophagus, stomach, pancreas, kidney, bladder, and cervix. Quitting at any age reduces risk — the body begins repairing tobacco-related damage almost immediately.
Maintain a Healthy Weight
Obesity is associated with increased risk for at least 13 types of cancer, including breast, colorectal, endometrial, kidney, and pancreatic cancers. The mechanisms include chronic inflammation, elevated insulin and estrogen levels, and altered immune function. Even modest weight loss reduces these risk markers.
Move Your Body
Regular physical activity independently reduces the risk of several cancers, including colon, breast, and endometrial cancer. The protective effect appears to operate through multiple pathways: lowering inflammation, improving insulin sensitivity, and supporting immune surveillance. Current guidelines recommend at least 150 minutes per week of moderate-intensity activity.
Limit Alcohol
Alcohol is a Group 1 carcinogen — in the same category as tobacco and asbestos. Even moderate drinking increases risk for breast, liver, colorectal, esophageal, and head and neck cancers. The safest amount of alcohol for cancer prevention is zero.
Protect Your Skin
UV radiation from the sun and tanning beds is the primary cause of skin cancer, including melanoma. Use broad-spectrum sunscreen, wear protective clothing, and avoid peak sun exposure. Check your skin regularly for new or changing moles — WatchMyHealth's skin care analysis feature can help you track skin changes over time.
Get Vaccinated
The HPV vaccine prevents cervical cancer (and several other HPV-related cancers), while the hepatitis B vaccine reduces liver cancer risk. These are among the most effective cancer prevention tools available.
Get Screened on Schedule
Screening catches cancer early, when treatment is most effective — or identifies pre-cancerous changes that can be addressed before cancer develops. Which screenings you need depends on your individual risk profile.
The Information Problem: Why Knowledge Matters as Much as Medicine
One of the most striking findings in cancer research has nothing to do with drugs or surgery. It's about information.
Studies consistently show that patients who understand their diagnosis, prognosis, and treatment options achieve better outcomes. A 2013 study found that cancer patients who were informed about their prognosis and involved in treatment decisions had better physical and emotional well-being. Informed patients are more likely to choose appropriate treatments, including experimental therapies that may offer their best chance.
The flip side is equally stark. Approximately 75% of late-stage cancer patients don't fully understand their prognosis. Many don't understand the goals of their own treatment — whether it's aimed at cure, life extension, or symptom relief. This knowledge gap can lead to overtreatment: up to one-third of people with metastatic cancer who died within a month of diagnosis received aggressive treatment that likely provided no benefit and may have worsened their final days.
On the other side, fear and misinformation cause some patients to refuse treatment even when chances of success are high.
The throughline is clear: the more you know about your own health — your risk factors, your screening status, your family history — the better positioned you are to make good decisions if you ever face a cancer diagnosis. Health literacy isn't just academic knowledge. It's a survival tool.
Beware the Miracle Cure
Wherever serious disease exists, exploitation follows. Cancer is no exception.
The desire for a cure — any cure — makes cancer patients especially vulnerable to fraud. In 2013, a U.S. minister was sentenced to 14 years for selling an herbal concoction he claimed cured incurable cancer in 60–80% of cases. In 2015, an American oncologist received 45 years in prison for deliberately misdiagnosing patients and prescribing unnecessary treatments to collect insurance payments.
One of the most damaging frauds involved bone marrow transplantation for breast cancer. A South African oncologist named Werner Bezwoda published studies claiming remarkable success rates — over 90% improvement. Approximately 40,000 women worldwide underwent the procedure based on his data before American researchers discovered that the results were entirely fabricated. Patients listed as "surviving" had died in hospice.
The lesson is painful but important: legitimate cancer treatment comes from evidence-based medicine, delivered by qualified oncologists, supported by peer-reviewed clinical trials. "Alternative" cancer cures, miracle supplements, and anyone promising guaranteed outcomes for advanced cancer should be treated with extreme skepticism.
If you or a loved one is navigating a cancer diagnosis, the best first step is a consultation with a board-certified oncologist — ideally at a comprehensive cancer center — and a clear understanding of the evidence behind any proposed treatment.
What the Future Looks Like
Cancer research is not stuck. Several frontiers hold genuine promise:
- Liquid biopsies. Blood tests that detect cancer DNA fragments could eventually enable screening for multiple cancers from a single blood draw, catching tumors far earlier than current methods.
- CAR-T cell therapy. Engineering a patient's own immune cells to recognize and attack their specific cancer has produced remarkable results in certain blood cancers, with active research extending the approach to solid tumors.
- AI-assisted diagnosis. Machine learning algorithms are being trained to detect cancers in imaging scans with accuracy matching or exceeding expert radiologists, potentially democratizing access to early detection.
- Cancer vaccines. mRNA vaccine technology (the same platform behind COVID-19 vaccines) is being adapted to create personalized cancer vaccines that teach the immune system to target each patient's specific tumor mutations.
- Combination immunotherapy. New combinations of immune-modulating drugs are pushing response rates higher for cancers that historically resisted immunotherapy.
None of these is a universal cure. But collectively, they represent a future where more cancers are caught earlier, treated more precisely, and managed more effectively — a world where cancer becomes less a death sentence and more a chronic condition that people live with for decades.
As oncologist Siddhartha Mukherjee has argued, the realistic goal is not to eliminate cancer entirely — a disease rooted in the fundamental mechanics of cell division cannot be fully eradicated, any more than aging can. Cancer has been with us since at least 3000 BCE. The goal is to outsmart it: to detect it before it becomes dangerous, to treat it with precision rather than blunt force, and to turn its deadliest forms into manageable chronic conditions.
What You Can Do Today
Cancer is complex, and no article can replace personalized medical guidance. But there are concrete, evidence-supported actions you can take right now:
Know your screening schedule. Are you up to date on the cancer screenings recommended for your age, sex, and risk factors? If you're not sure, WatchMyHealth's preventive health screening tool can generate personalized recommendations based on your profile and current clinical guidelines.
Track your physician visits. Regular check-ups are the backbone of preventive care. Use a physician visit tracker to ensure you're not overdue for important appointments — especially cancer screenings with specific time intervals (annual mammograms, colonoscopies every 10 years starting at 45, etc.).
Address modifiable risk factors. If you smoke, pursue cessation. If you're carrying excess weight, even modest loss helps. If you're sedentary, start with consistent walking. Track these behaviors over time — the trend matters more than any single day.
Build health literacy. Understand your family cancer history. Know which cancers run in your family, at what ages they occurred, and whether genetic testing might be appropriate. This information directly determines which screenings you need and when.
Monitor your mental health. A cancer diagnosis, or even cancer anxiety, takes a serious psychological toll. WatchMyHealth's health assessments — including the PHQ-9 for depression and GAD-7 for anxiety — can help you monitor your emotional baseline and flag changes that warrant professional attention.
Don't delay symptoms. Persistent unexplained weight loss, new lumps, changes in bowel habits, unusual bleeding, persistent cough, skin changes — these deserve prompt medical evaluation. Most won't be cancer. But the ones that are will be caught earlier.
The most powerful weapon against cancer isn't a single drug or procedure. It's a system: awareness, screening, early detection, informed decision-making, and access to evidence-based treatment. The closer you are to understanding your own health, the better your odds — for cancer and for everything else.
